B De Bernardi
Overview
Explore the profile of B De Bernardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
1519
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Cataldo A, Agodi A, Balaguer J, Garaventa A, Barchitta M, Segura V, et al.
Clin Transl Oncol
. 2016 Apr;
19(1):76-83.
PMID: 27041689
Introduction: SIOPEN INES protocol yielded excellent 5-year survival rates for MYCN-non-amplified metastatic neuroblastoma. Patients deemed ineligible due to lack or delay of MYCN status or late registration were treated, but...
2.
Gigliotti A, De Ioris M, De Grandis E, Podda M, Cellini M, Sorrentino S, et al.
Pediatr Hematol Oncol
. 2016 Feb;
33(2):94-101.
PMID: 26901768
The occurrence of congenital neuroblastoma presenting at birth with symptoms of epidural compression secondary to spinal canal invasion is rare. Almost all cases reported in the literature have survived from...
3.
Granata C, Haupt R, Mazzaferro V, Fratino G, Mattioli G, Gasparini M, et al.
Pediatr Surg Int
. 2013 Sep;
11(5-6):398-9.
PMID: 24057728
The authors report a rate case of carcinoid syndrome (CS) in a 12-year-old child that was caused by a carcinoid tumor located in the ileum that had metastasized mainly to...
4.
Schleiermacher G, Michon J, Ribeiro A, Pierron G, Mosseri V, Rubie H, et al.
Br J Cancer
. 2011 Dec;
105(12):1940-8.
PMID: 22146831
Background: In neuroblastoma (NB), the presence of segmental chromosome alterations (SCAs) is associated with a higher risk of relapse. Methods: In order to analyse the role of SCAs in infants...
5.
De Bernardi B, Mosseri V, Rubie H, Castel V, Foot A, Ladenstein R, et al.
Br J Cancer
. 2008 Sep;
99(7):1027-33.
PMID: 18766186
Main objective of this study was to confirm that surgery alone is an effective and safe treatment for localised resectable neuroblastoma except stage 2 with amplified MYCN gene (MYCNA). Of...
6.
7.
Conte M, Carlini C, Hanau G, Rizzo A, Biasotti S, Sementa A, et al.
Pediatr Med Chir
. 2004 Apr;
25(5):387-9.
PMID: 15058844
The Authors describe the case of a 8-y female with an abdominal GN who developed nine years later an ovarian tumor. This association is an unusual and noteworthy event.
8.
Ambros I, Benard J, Boavida M, Bown N, Caron H, Combaret V, et al.
J Clin Oncol
. 2003 May;
21(11):2077-84.
PMID: 12775732
Purpose: Therapy stratification based on genetic markers is becoming increasingly important, which makes commitment to the highest possible reliability of the involved markers mandatory. In neuroblastic tumors, amplification of the...
9.
Ambros P, Ambros I, Kerbl R, Luegmayr A, Rumpler S, Ladenstein R, et al.
Med Pediatr Oncol
. 2001 Jul;
36(1):1-4.
PMID: 11464855
Background: At least three genetic hallmarks identify aggressive tumour behaviour in neuroblastomas; amplification of the oncogene MYCN; deletion (loss of heterozygosity [LOH]) at the short arm of chromosome 1 (del1p36),...
10.
Campus R, Conte M, Rizzo A, Granata C, Gambini C, Carlini C, et al.
Pediatr Med Chir
. 2001 Jun;
22(1):47-8.
PMID: 11387767
One of the typical presentations of neuroblastoma is intractable diarrhea or wdha (watery diarrhea, hypokalemia, achloridria). The case admitted to our Pediatric Surgery Department presented watery diarrhea due to VIP...